IMPORTANT NOTICE: Our email addresses will soon change. Learn more >>
Loading...

FITC anti-mouse Ly-6C Antibody

Pricing & Availability
Clone
HK1.4 (See other available formats)
Regulatory Status
RUO
Other Names
Lymphocyte antigen 6 complex, locus C
Isotype
Rat IgG2c, κ
Ave. Rating
Submit a Review
Product Citations
publications
HK1dot4_FITC_011409.jpg
C57BL/6 bone marrow cells stained with HK1.4 FITC (gated on myeloid cell population)
  • HK1dot4_FITC_011409.jpg
    C57BL/6 bone marrow cells stained with HK1.4 FITC (gated on myeloid cell population)
Compare all formats See FITC spectral data
Cat # Size Price Quantity Check Availability Save
128005 50 µg 72€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
128006 500 µg 235€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Most hematopoietic cells express one or more members of Ly-6 family. The expression of Ly-6 varies with development stage and activation. Ly-6C is a 14-17 kD GPI-linked surface protein expressed on mouse monocyte/macrophage cells, endothelial cells, neutrophils, and some T cell subsets. Ly-6C is reported to be an indicator of memory CD8+ T cells.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
L3 cloned CTL cells
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume or 100 µl of whole blood. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Application Notes

Clone HK1.4 does not block the binding of clone RB6-8C58.

Additional reported applications (for relevant formats of this clone) include: in vitro activation of T cells1-3 and immunohistochemistry of frozen sections4.

Application References
  1. Jutila MA, et al. 1988. Eur. J. Immunol. 18:1819. (Activ)
  2. Herold KC, et al. 1990. Diabetes 39:815. (Activ)
  3. Havran WL, et al. 1988. J. Immunol. 140:1034 (Activ)
  4. Flanagan K, et al. 2008. J. Immunol. 180:3874. (IHC)
  5. Makaroff LE, et al. 2009. P. Natl. Acad. Sci. USA 106:4799. (FC)
  6. Zuber J, et al. 2009. Genes Dev. 23:877. (FC) PubMed
  7. Ribechini E, et al. 2009. Eur. J. Immunol. 39:3538.
  8. Ma C, et al. 2012. J. Leukoc. Biol. 92:1199.
  9. Watson NB, et al. 2015. J Immunol. 194:2796. PubMed
Product Citations
  1. Duan Y, et al. 2019. Circ Res. 125:969. PubMed
  2. Combes F, et al. 2018. Neoplasia. 20:848. PubMed
  3. de la Rosa X, et al. 2018. Am J Pathol. 188:950. PubMed
  4. Ying W, et al. 2019. Cell Metab. 29:457. PubMed
  5. Fang C, et al. 2022. J Pathol. 256:310. PubMed
  6. Xin B, et al. 2022. Hepatology. 76:630. PubMed
  7. Du Y, et al. 2022. FASEB J. 36:e22248. PubMed
  8. Helfen A, et al. 2022. Neoplasia. 28:100792. PubMed
  9. Liu X, et al. 2022. Adv Sci (Weinh). 9:e2105650. PubMed
  10. Mirchandani AS, et al. 2022. Nat Immunol. 23:927. PubMed
  11. Campisi L, et al. 2022. Nature. 606:945. PubMed
  12. Silva Pereira S, et al. 2022. Elife. 11: . PubMed
  13. McAlpine CS, et al. 2022. J Exp Med. 219: . PubMed
  14. Millar FR, et al. 2022. Cell Rep. 41:111596. PubMed
  15. He Y, et al. 2022. Front Immunol. 13:986202. PubMed
  16. Soni N, et al. 2022. FASEB Bioadv. 4:798. PubMed
  17. Marritt KL, et al. 2023. Front Immunol. 13:1087991. PubMed
  18. Kulkarni R, et al. 2023. Life Sci Alliance. 6: . PubMed
  19. Meng S, et al. 2023. Stem Cell Investig. 10:2. PubMed
  20. Hettwer J, et al. 2022. Cardiovasc Res. 118:2778. PubMed
  21. Fernández-García V, et al. 2022. Biomed Pharmacother. 148:112769. PubMed
  22. Chen K, et al. 2022. Adv Sci (Weinh). 9:e2104106. PubMed
  23. Mise Y, et al. 2022. Carcinogenesis. 43:647. PubMed
  24. Lopez R, et al. 2022. Nat Biotechnol. 40:1360. PubMed
  25. Sanmarco LM, et al. 2022. Nature. 611:801. PubMed
  26. Pagni RL, et al. 2022. Front Immunol. 13:1005937. PubMed
  27. Aso K, et al. 2023. Nat Commun. 14:984. PubMed
  28. Bautista CA, et al. 2023. Front Physiol. 14:1122348. PubMed
  29. He Y, et al. 2023. Biomolecules. 13:. PubMed
  30. Lin CH, et al. 2023. iScience. 26:106904. PubMed
  31. Liang J, et al. 2021. Cancer Manag Res. 13:6977. PubMed
  32. Rosina M, et al. 2022. Cell Metab. 34:533. PubMed
  33. DeSouza-Vieira T, et al. 2020. Cell Rep. 33:108317. PubMed
  34. Liu Y, et al. 2021. Cell Metabolism. 33(6):1221-1233.e11. PubMed
  35. Zaman R, et al. 2021. Immunity. :. PubMed
  36. Jackson A, et al. 2014. J Leukoc Biol. 92:609. PubMed
  37. Jones NM, et al. 2019. BMC Cancer. 1.127777778. PubMed
  38. John S, et al. 2020. Sci Rep. 10:11377. PubMed
  39. Frisbee AL, et al. 2019. Nat Commun. 10:2712. PubMed
  40. Hastings AK, et al. 2019. iScience. 13:339. PubMed
  41. Schloss MJ, et al. 2022. Nat Immunol. 23:605. PubMed
  42. Keeter WC, et al. 2022. Eur Heart J Open. 2:oeac028. PubMed
  43. Fan L, et al. 2021. Cancers (Basel). 13:. PubMed
  44. Rødahl I, et al. 2021. STAR Protoc. 2:100842. PubMed
  45. Bouchareychas L, et al. 2021. iScience. 24(8):102847. PubMed
  46. You Y, et al. 2016. Sci Rep. 6:20630. PubMed
  47. Kim TJ, et al. 2019. Nat Commun. 10:3258. PubMed
  48. Saleh MM, et al. 2019. Cell Host Microbe. 25:756. PubMed
  49. Dong L, et al. 2021. Cancer Cell. . PubMed
  50. Zhang Z, et al. 2020. J Immunol. 204:3400. PubMed
  51. Rao E, et al. 2021. Sci Immunol. 6:. PubMed
  52. Shani O, et al. 2020. Cancer Res. 80:5317. PubMed
  53. Buzas K, et al. 2011. Cytokine. 55:429. PubMed
  54. Rybalko V, et al. 2015. PLoS One. 10: 0145550. PubMed
  55. Ohtsuki T, et al. 2016. J Virol. 90: 300 - 307. PubMed
  56. Iwata H, et al. 2016. Nat Commun. 7:12849. PubMed
  57. McAlpine CS, et al. 2019. Nature. 566:383. PubMed
  58. Misumi I et al. 2019. Cell Rep. 27(2):514-524 . PubMed
  59. Paprckova D, et al. 2022. Front Immunol. 13:1009198. PubMed
  60. Chen JS, et al. 2022. Sci Immunol. 7:eabl5652. PubMed
  61. Dolgova EV, et al. 2022. Int J Mol Sci. 23:. PubMed
  62. Uroda T, et al. 2020. Nat Protoc. 15:2107. PubMed
  63. Go DM, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:715. PubMed
  64. Ellis G, et al. 2015. EMBO Rep. 16: 1203-1218. PubMed
  65. Mirakaj V, et al. 2014. J Exp Med. 211:1037. PubMed
  66. Park Y, et al. 2013. Cancer Res . 73:5669. PubMed
  67. Schlegel M, et al. 2018. J Clin Invest. 128:4711. PubMed
  68. Al-Sharea A, et al. 2017. Cell Cycle. 10.1016/j.atherosclerosis.2017.08.010. PubMed
  69. Bhattacharya P, et al. 2022. PLoS Negl Trop Dis. 16:e0010224. PubMed
  70. Zhang Z, et al. 2021. Oncoimmunology. 10:1912472. PubMed
  71. Yu AI, et al. 2020. Cell Rep. 107471:31. PubMed
  72. Moreau GB, et al. 2020. Am J Trop Med Hyg. 103:1215. PubMed
  73. Shin SH, et al. 2022. Front Cell Neurosci. 16:844480. PubMed
  74. Eichin D, et al. 2015. PLoS One. 10: 0134721. PubMed
  75. Xiao P, et al. 2019. J Exp Med. 216:337. PubMed
  76. Fatkhullina AR et al. 2018. Immunity. 49(5):943-957 . PubMed
  77. McAlpine CS, et al. 2021. Nature. 595:701. PubMed
  78. Naler LB, et al. 2022. Commun Biol. 5:102. PubMed
  79. Lehmann M, et al. 2016. J Leukoc Biol. 99: 1057 - 1064. PubMed
  80. Körner A, et al. 2019. Nat Commun. 10:633. PubMed
  81. Hulsmans M et al. 2017. Cell. 169(3):510-522 . PubMed
  82. Grune J, et al. 2022. Nat Cardiovasc Res. 1:649. PubMed
  83. Cao Y, et al. 2015. J Biol Chem. 290: 23050-23063. PubMed
  84. Körner A, et al. 2019. Proc Natl Acad Sci U S A. 116:20623. PubMed
  85. Kulkarni U, et al. 2019. Mucosal Immunol. 12:545. PubMed
  86. Suresh MV, et al. 2019. JCI Insight. 4:e133103. PubMed
  87. Liu T, et al. 2022. Front Immunol. 13:901349. PubMed
  88. Yong L, et al. 2022. Nat Commun. 13:4255. PubMed
  89. He Y, et al. 2021. Front Immunol. 12:641206. PubMed
  90. Uddin MJ, et al. 2022. Mucosal Immunol. 15:165. PubMed
  91. Reinfeld BI, et al. 2021. Nature. 593:282. PubMed
  92. Han D, et al. 2021. J Immunol Res. 6688053:2021. PubMed
  93. Volberding PJ, et al. 2021. Cell Reports. 35(8):109160. PubMed
  94. Xu Y, et al. 2016. Arthritis Rheum. 67: 225-237. PubMed
  95. Ma H, Wan S, Xia C 2016. J Leukoc Biol. 99: 1121 - 1129. PubMed
  96. Li Y, et al. 2020. Cell Reports. 27(10):2809-2816.e3.. PubMed
  97. Körner A,et al. 2017. Cell Death Differ.. 10.1038/cdd.2017.177. PubMed
  98. He J, et al. 2019. J Clin Invest. 130. PubMed
  99. Monteran L, et al. 2022. Nat Commun. 13:5797. PubMed
  100. Guldner IH, et al. 2020. Cell. 183(5):1234-1248.e25. PubMed
  101. Trefzer A, et al. 2021. Cell Reports. 34(6):108748. PubMed
  102. Tan X, et al. 2015. Sci Rep. 5: 15702. PubMed
  103. Smith CA, et al. 2019. JCI Insight. 4. PubMed
  104. Yu X, et al. 2019. Nat Commun. 10:574. PubMed
  105. Cohen M et al. 2018. Cell. 175(4):1031-1044 . PubMed
  106. Puigdelloses M, et al. 2021. J Immunother Cancer. 9:. PubMed
  107. Poczobutt JM, et al. 2021. Am J Respir Cell Mol Biol. 64:629. PubMed
  108. Li C, et al. 2021. Cell Metabolism. 33(8):1610-1623.e5. PubMed
  109. Ballesteros I, et al. 2020. Cell. 183(5):1282-1297.e18. PubMed
  110. Ni J, et al. 2020. Immunity. 52(6):1075-1087.e8. PubMed
  111. Garcia-Bonilla L, et al. 2014. J Immunol. 193:2531. PubMed
  112. Lee S, et al. 2011. J Immunol. 186:6972. PubMed
  113. Li D, et al. 2022. Emerg Microbes Infect. 11:2248. PubMed
  114. Gomez S, et al. 2022. J Immunother Cancer. 10:. PubMed
  115. Moore J, et al. 2015. Am J Physiol Heart Circ Physiol. 309: 906-917. PubMed
  116. León-Cabrera S, et al. 2014. Int J Biol Sci. 9 948 . PubMed
  117. Alvarez-Breckenridge C, et al. 2012. J Virol. 86:4566. PubMed
  118. Hightower RM, et al. 2019. Mol Ther. 28:189. PubMed
  119. Zhao T, et al. 2022. JCI Insight. 7:. PubMed
  120. Murdock BJ, et al. 2021. JCI Insight. 6:. PubMed
  121. Derada Troletti C, et al. 2021. Cell Reports. 35(9):109201. PubMed
  122. Hou PP, et al. 2020. Molecular Cell. 78(6):1192-1206.e10. PubMed
  123. Xu G, et al. 2020. Cell Rep. 32:108170. PubMed
  124. Liu Y, et al. 2015. BioMed Res Int. 2015 563425. PubMed
  125. Chiang N, et al. 2019. J Clin Invest. 129:5294. PubMed
  126. Alexander Mildner et al. 2017. Immunity. 46(5):849-862 . PubMed
  127. Yang YS, et al. 2022. Nat Commun. 13:6175. PubMed
  128. Wong NR, et al. 2021. Immunity. 54:2072. PubMed
  129. Kwak T, et al. 2020. Cell Reports. 33(13):108571. PubMed
  130. Baumann D, et al. 2020. Nat Commun. 1.969444444. PubMed
  131. Ji L et al. 2019. Immunity. 51(2):272-284 . PubMed
  132. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  133. Hobbs BE, et al. 2021. Pathogens. 10:. PubMed
  134. Montes de Oca M, et al. 2016. PLoS Pathog. 12: 1005398. PubMed
  135. Roediger B et al. 2018. Cell. 175(2):530-543 . PubMed
  136. Meng Michelle Xu et al. 2017. Immunity. 47(2):363-373 . PubMed
  137. Caballero S, et al. 2017. Invest Ophthalmol Vis Sci. 58:5164. PubMed
  138. Tang S, et al. 2022. Virol J. 19:32. PubMed
  139. Knuplez E, et al. 2021. British Journal of Pharmacology. 178(5):1234-1248. PubMed
  140. Donlan AN, et al. 2021. JCI Insight. 6: . PubMed
  141. Tyagi A, et al. 2021. Nat Commun. 12:474. PubMed
  142. Aryal B, et al. 2016. Nat Commun. 7:12313. PubMed
  143. Ngkelo A, et al. 2016. J Exp Med. 213: 1353 - 1374. PubMed
  144. Garcia-Bonilla L, et al. 2015. J Neurosci. 35: 14783 - 14793. PubMed
  145. Ramanan D, et al. 2020. Cell. 181(6):1276-1290. PubMed
  146. Nguyen HX et al. 2017. J Neurosci. 37(38):9269-9287 . PubMed
  147. Asahara M, et al. 2022. PLoS One. 17:e0276135. PubMed
  148. Dye BR, et al. 2020. Biomaterials. 234:119757. PubMed
  149. Lei Y, et al. 2021. Sci Adv. 7:. PubMed
  150. Guan D, et al. 2021. Cell Death Dis. 12:431. PubMed
  151. Tummala G, et al. 2021. Invest Ophthalmol Vis Sci. 62:41. PubMed
  152. Chetty A, et al. 2021. Cell Host Microbe. 29:579. PubMed
  153. Chavkin NW, et al. 2021. J Am Heart Assoc. 10:e019904. PubMed
  154. Rahtes A, et al. 2020. Front Immunol. 1.484722222. PubMed
  155. Hegde V, et al. 2015. J Immunol. 194:5211. PubMed
  156. Aguado B, et al. 2015. Sci Rep. 5: 17566. PubMed
  157. Hilt ZT, et al. 2019. JCI Insight. 4:5. PubMed
  158. Jones GS, et al. 2020. mSphere. 5:. PubMed
  159. Tran S, et al. 2020. Immunity. 53(3):627-640.e5. PubMed
  160. Akhand SS, et al. 2020. Cancer Immunol Res. 8:1542. PubMed
  161. Reinke S, et al. 2020. Cell Reports. 30(8):2501-2511. PubMed
  162. Ershaid N, et al. 2019. Nat Commun. 10:4375. PubMed
  163. Abe H, et al. 2019. Nat Commun. 10:2824. PubMed
  164. Song X, et al. 2022. Transl Oncol. 15:101306. PubMed
  165. Yang F, et al. 2021. Nat Commun. 12:3424. PubMed
  166. Galeano Nio JL, et al. 2020. eLife. 9:00. PubMed
RRID
AB_1186134 (BioLegend Cat. No. 128005)
AB_1186134 (BioLegend Cat. No. 128006)

Antigen Details

Structure
14-17 kD protein (134 amino acids), member of the Ly-6 family of GPI linked protein. Ly6 family members share structure homology throughout a distinctive cystein rich protein domain that incorporates O-linked carbohydrates.
Distribution

Ly-6C is expressed primarily on bone marrow myeloid populations, monocytes/macrophages, neutrophils, endothelial cells, and some T cell subsets. Ly-6C is also a marker of memory CD8+ T cells.

Cell Type
Endothelial cells, Macrophages, Monocytes, Neutrophils, T cells
Biology Area
Immunology
Molecular Family
CD Molecules
Antigen References

1. Jutila MA, et al. 1988. Eur. J. Immunol. 18:1819.
2. Cerwenka A, et al. 1998. J. Immunol. 161:97.

Gene ID
17067 View all products for this Gene ID
UniProt
View information about Ly-6C on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All Ly-6C Reagents Request Custom Conjugation
Description Clone Applications
Pacific Blue™ anti-mouse Ly-6C HK1.4 FC
APC anti-mouse Ly-6C HK1.4 FC
Purified anti-mouse Ly-6C HK1.4 FC,IHC-F
Biotin anti-mouse Ly-6C HK1.4 FC
FITC anti-mouse Ly-6C HK1.4 FC
Alexa Fluor® 647 anti-mouse Ly-6C HK1.4 FC
PE anti-mouse Ly-6C HK1.4 FC
PerCP/Cyanine5.5 anti-mouse Ly-6C HK1.4 FC
PE/Cyanine7 anti-mouse Ly-6C HK1.4 FC
Alexa Fluor® 488 anti-mouse Ly-6C HK1.4 FC
Alexa Fluor® 700 anti-mouse Ly-6C HK1.4 FC
APC/Cyanine7 anti-mouse Ly-6C HK1.4 FC
PerCP anti-mouse Ly-6C HK1.4 FC
Brilliant Violet 570™ anti-mouse Ly-6C HK1.4 FC
Brilliant Violet 421™ anti-mouse Ly-6C HK1.4 FC
Brilliant Violet 510™ anti-mouse Ly-6C HK1.4 FC
Brilliant Violet 605™ anti-mouse Ly-6C HK1.4 FC
Brilliant Violet 711™ anti-mouse Ly-6C HK1.4 FC
Purified anti-mouse Ly-6C (Maxpar® Ready) HK1.4 FC,CyTOF®
Brilliant Violet 785™ anti-mouse Ly-6C HK1.4 FC
PE/Dazzle™ 594 anti-mouse Ly-6C HK1.4 FC
APC/Fire™ 750 anti-mouse Ly-6C HK1.4 FC
TotalSeq™-A0013 anti-mouse Ly-6C HK1.4 PG
Brilliant Violet 650™ anti-mouse Ly-6C HK1.4 FC
TotalSeq™-C0013 anti-mouse Ly-6C HK1.4 PG
TotalSeq™-B0013 anti-mouse Ly-6C HK1.4 PG
APC/Fire™ 810 anti-mouse Ly-6C Antibody HK1.4 FC
Spark Red™ 718 anti-mouse Ly-6C HK1.4 FC
Spark UV™ 387 anti-mouse Ly-6C HK1.4 FC
PE/Fire™ 810 anti-mouse Ly-6C HK1.4 FC
Spark Blue™ 550 anti-mouse Ly-6C (Flexi-Fluor™) HK1.4 FC
Spark Blue™ 574 anti-mouse Ly-6C (Flexi-Fluor™) HK1.4 FC
PE/Cyanine5 anti-mouse Ly-6C HK1.4 FC
Go To Top Version: 2    Revision Date: 12/09/2013

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account